<DOC>
	<DOCNO>NCT00911235</DOCNO>
	<brief_summary>This study design estimate effect fluconazole ( 200 mg BID 2 day ) , moderate CYP3A4 inhibitor pharmacokinetics single 8 mg oral dose fesoterodine healthy adult subject .</brief_summary>
	<brief_title>The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Urinary Incontinence , Urge</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>Healthy subject age 18 55 year Not healthy subject . subject acute chronic medical psychiatric condition laboratory abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects</keyword>
</DOC>